Mainz Biomed is a medical - diagnostics & research company in the healthcare sector on NASDAQ, led by Guido Bächler, with a market cap of $8.8M. As of Q3 2025, 11% of shares are held by 13 institutional investors, with ARMISTICE CAPITAL, LLC as the largest holder at 8.62%.
Overview of institutional ownership in MYNZ as of Q3 2025 with a market cap of $6.8M
Based on market cap of $6.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in MYNZ as of Q3 2025
| Institution | Position Value |
|---|---|
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | $587.8K 0.02% of portfolio |
D Dauntless Investment Group, LLC Institution | $76.0K 0.20% of portfolio |
Journey Advisory Group, LLC RIA/Wealth | $22.4K 0.00% of portfolio |
$14.9K 0.00% of portfolio | |
UBS Group AG Institution | $10.4K 0.00% of portfolio |
A Advisor Group Holdings, Inc. Institution | $3.1K 0.00% of portfolio |
Provenance Wealth Advisors, LLC RIA/Wealth | $1.7K 0.00% of portfolio |
Newbridge Financial Services Group, Inc. RIA/Wealth | $745.0 0.00% of portfolio |
S SBI Securities Co., Ltd. Institution | $502.0 0.00% of portfolio |
IFP Advisors, Inc RIA/Wealth | $134.0 0.00% of portfolio |
Institutional buying and selling activity for MYNZ in Q3 2025
| Institution | Net Bought |
|---|---|
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | +$163.2K +109.5K shares |
D Dauntless Investment Group, LLC Institution | +$1.5K +1.0K shares |
A Advisor Group Holdings, Inc. Institution | +$1.5K +1.0K shares |
ROTHSCHILD INVESTMENT LLC RIA/Wealth | +$127.0 +85.0 shares |
MORGAN STANLEY RIA/Wealth | +$3.0 +-860.0 shares |
| Institution | Net Sold |
|---|---|
L LPL Financial LLC Institution | −$16.5K −11.7K shares |
UBS Group AG Institution | −$4.2K −2.8K shares |
S SBI Securities Co., Ltd. Institution | −$4.5 −3.0 shares |
RAYMOND JAMES FINANCIAL INC RIA/Wealth | −$1.0 −1.0 shares |
Institutions that initiated new positions or completely exited MYNZ in Q3 2025
| Institution | Position Value |
|---|---|
ROTHSCHILD INVESTMENT LLC RIA/Wealth | $127.0 85.0 shares |
| Institution | Previous Position |
|---|---|
L LPL Financial LLC Institution | $16.5K 11.7K shares |
RAYMOND JAMES FINANCIAL INC RIA/Wealth | $1.0 1.0 shares |
Institutions with the largest Call and Put options positions in MYNZ as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with MYNZ as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
D Dauntless Investment Group, LLC Institution | 0.20% $76.0K |
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | 0.02% $587.8K |
Journey Advisory Group, LLC RIA/Wealth | 0.00% $22.4K |
Provenance Wealth Advisors, LLC RIA/Wealth | 0.00% $1.7K |
Newbridge Financial Services Group, Inc. RIA/Wealth | 0.00% $745.0 |
0.00% $14.9K | |
S SBI Securities Co., Ltd. Institution | 0.00% $502.0 |
ROTHSCHILD INVESTMENT LLC RIA/Wealth | 0.00% $127.0 |
A Advisor Group Holdings, Inc. Institution | 0.00% $3.1K |
IFP Advisors, Inc RIA/Wealth | 0.00% $134.0 |
Discover hedge funds investing in MYNZ

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $201.1M | 6.38% | |
Biotechnology Healthcare | $160.7M | 5.10% | |
Drug Manufacturers - Specialty & Generic Healthcare | $135.5M | 4.30% |
We use cookies for analytics. See our Privacy and Cookie Policy.